JP2022527270A5 - - Google Patents
Info
- Publication number
- JP2022527270A5 JP2022527270A5 JP2021557231A JP2021557231A JP2022527270A5 JP 2022527270 A5 JP2022527270 A5 JP 2022527270A5 JP 2021557231 A JP2021557231 A JP 2021557231A JP 2021557231 A JP2021557231 A JP 2021557231A JP 2022527270 A5 JP2022527270 A5 JP 2022527270A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- disease
- pharmaceutical
- combination
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962824190P | 2019-03-26 | 2019-03-26 | |
| US62/824,190 | 2019-03-26 | ||
| PCT/IB2020/052825 WO2020194209A1 (en) | 2019-03-26 | 2020-03-25 | Isothiazolidine 1,1-dioxide and 1,4-butan sultone containing rapamycin derivatives and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022527270A JP2022527270A (ja) | 2022-06-01 |
| JP2022527270A5 true JP2022527270A5 (https=) | 2023-04-03 |
| JP7461369B2 JP7461369B2 (ja) | 2024-04-03 |
Family
ID=70190042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557231A Active JP7461369B2 (ja) | 2019-03-26 | 2020-03-25 | イソチアゾリジン１，１－ジオキシド及び１，４－ブタンスルトン含有ラパマイシン誘導体並びにその使用 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20220202787A1 (https=) |
| EP (1) | EP3947392B1 (https=) |
| JP (1) | JP7461369B2 (https=) |
| KR (1) | KR20210142689A (https=) |
| CN (1) | CN113614090B (https=) |
| AU (1) | AU2020250026B2 (https=) |
| BR (1) | BR112021018692A2 (https=) |
| CA (1) | CA3134653A1 (https=) |
| DK (1) | DK3947392T3 (https=) |
| ES (1) | ES2987625T3 (https=) |
| FI (1) | FI3947392T3 (https=) |
| HR (1) | HRP20240633T1 (https=) |
| HU (1) | HUE067396T2 (https=) |
| LT (1) | LT3947392T (https=) |
| MX (1) | MX2021011376A (https=) |
| PL (1) | PL3947392T3 (https=) |
| PT (1) | PT3947392T (https=) |
| RS (1) | RS65531B1 (https=) |
| SI (1) | SI3947392T1 (https=) |
| WO (1) | WO2020194209A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR112834A1 (es) | 2017-09-26 | 2019-12-18 | Novartis Ag | Derivados de rapamicina |
| WO2019241789A1 (en) | 2018-06-15 | 2019-12-19 | Navitor Pharmaceuticals, Inc. | Rapamycin analogs and uses thereof |
| HRP20250197T1 (hr) | 2018-12-18 | 2025-04-11 | Novartis Ag | Derivati rapamicina |
| AU2020397938A1 (en) | 2019-12-05 | 2022-06-23 | Janssen Pharmaceutica Nv | Rapamycin analogs and uses thereof |
| JP2023028473A (ja) * | 2021-08-19 | 2023-03-03 | 日本マイクロバイオファーマ株式会社 | エベロリムスの製造方法 |
| GB202415232D0 (en) | 2024-10-16 | 2024-11-27 | Nacamed As | Composition |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA737247B (en) | 1972-09-29 | 1975-04-30 | Ayerst Mckenna & Harrison | Rapamycin and process of preparation |
| ZA935112B (en) * | 1992-07-17 | 1994-02-08 | Smithkline Beecham Corp | Rapamycin derivatives |
| CA2257803C (en) * | 1996-07-12 | 2008-12-02 | Ariad Pharmaceuticals, Inc. | Non immunosuppressive antifungal rapalogs |
| ATE264863T1 (de) * | 1999-08-24 | 2004-05-15 | Ariad Gene Therapeutics Inc | 28-epirapaloge |
| US20090023768A1 (en) * | 2006-02-24 | 2009-01-22 | Novartis Ag | Rapamycin derivatives for treating neuroblastoma |
| JP6130391B2 (ja) | 2011-11-23 | 2017-05-17 | インテリカイン， エルエルシー | Ｍｔｏｒ阻害剤を使用する強化された治療レジメン |
| US10683308B2 (en) * | 2015-09-11 | 2020-06-16 | Navitor Pharmaceuticals, Inc. | Rapamycin analogs and uses thereof |
| AR112834A1 (es) * | 2017-09-26 | 2019-12-18 | Novartis Ag | Derivados de rapamicina |
-
2020
- 2020-03-25 US US17/442,733 patent/US20220202787A1/en active Pending
- 2020-03-25 RS RS20240515A patent/RS65531B1/sr unknown
- 2020-03-25 JP JP2021557231A patent/JP7461369B2/ja active Active
- 2020-03-25 FI FIEP20717312.1T patent/FI3947392T3/fi active
- 2020-03-25 HU HUE20717312A patent/HUE067396T2/hu unknown
- 2020-03-25 MX MX2021011376A patent/MX2021011376A/es unknown
- 2020-03-25 WO PCT/IB2020/052825 patent/WO2020194209A1/en not_active Ceased
- 2020-03-25 CA CA3134653A patent/CA3134653A1/en active Pending
- 2020-03-25 KR KR1020217033691A patent/KR20210142689A/ko active Pending
- 2020-03-25 PL PL20717312.1T patent/PL3947392T3/pl unknown
- 2020-03-25 SI SI202030428T patent/SI3947392T1/sl unknown
- 2020-03-25 CN CN202080022154.4A patent/CN113614090B/zh active Active
- 2020-03-25 BR BR112021018692A patent/BR112021018692A2/pt unknown
- 2020-03-25 PT PT207173121T patent/PT3947392T/pt unknown
- 2020-03-25 EP EP20717312.1A patent/EP3947392B1/en active Active
- 2020-03-25 ES ES20717312T patent/ES2987625T3/es active Active
- 2020-03-25 HR HRP20240633TT patent/HRP20240633T1/hr unknown
- 2020-03-25 LT LTEPPCT/IB2020/052825T patent/LT3947392T/lt unknown
- 2020-03-25 AU AU2020250026A patent/AU2020250026B2/en active Active
- 2020-03-25 DK DK20717312.1T patent/DK3947392T3/da active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022527270A5 (https=) | ||
| JP2022514254A5 (https=) | ||
| JP2020535134A5 (https=) | ||
| HRP20240199T1 (hr) | Derivati rapamicina | |
| JP2020189879A5 (https=) | ||
| JP6964096B2 (ja) | ３−オキソ−２，６−ジフェニル−２，３−ジヒドロピリダジン−４−カルボキサミド類 | |
| US10414732B2 (en) | Polymorphic compounds and uses thereof | |
| HRP20240633T1 (hr) | Izotiazolidin 1,1-dioksid i 1,4-butan sulton derivati rapamicina i njihova uporaba | |
| JP2017505784A5 (https=) | ||
| JP2019532029A5 (https=) | ||
| RU2020121150A (ru) | Твердые формы ингибитора калликреина плазмы и его солей | |
| JP2006508970A5 (https=) | ||
| RU2004109818A (ru) | Производные пирролидинона | |
| NO336734B1 (no) | Preparater inneholdende 5-(benz-(Z)-yliden)-tiazolidin-4-on-derivater som immunundertrykkende midler samt anvendelse derav | |
| CA3137301A1 (en) | Polymorphic compounds and uses thereof | |
| JP2020502047A5 (https=) | ||
| WO2006019962B1 (en) | Compositions and methods for treatment of colitis | |
| JP2015508092A5 (https=) | ||
| JP2010508363A5 (https=) | ||
| IL287159B1 (en) | Small molecules agonists for FXR (farnesoid X receptor) and method for their preparation and use | |
| HRP20250197T1 (hr) | Derivati rapamicina | |
| JP2021523240A5 (https=) | ||
| JP2020517619A5 (https=) | ||
| FR2802530A1 (fr) | Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2,4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant | |
| RU2021130616A (ru) | Производные рапамицина, содержащие изотиазолидин-1,1-диоксид и 1,4-бутансультон, и пути их применения |